Betta Pharmaceuticals Co.,Ltd (SZSE:300558) won the bid and signed an agreement to acquire remaining 22.6% stake in AnewPharma Company, Ltd. from Shanghai Zhangjiang Biomedical Industry Venture Capital Co., Ltd. and Shanghai Zhangjiang Technology Venture Capital Co., Ltd. for approximately CNY 110 million on June 16, 2017. AnewPharma Company, Ltd. reported total assets of CNY 16.9 million, net assets of CNY 16.3 million, revenue of CNY 0 million, operating loss of CNY 13.9 million and net loss of CNY 10.9 million for the year ended December 31, 2016. Betta Pharmaceuticals Co., Ltd. (SZSE:300558) cancelled the acquisition of remaining 22.6% stake in AnewPharma Company, Ltd. from Shanghai Zhangjiang Biomedical Industry Venture Capital Co., Ltd. and Shanghai Zhangjiang Technology Venture Capital Co., Ltd. on June 16, 2018.